Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
非人灵长类结核杆菌生存的遗传要求
基本信息
- 批准号:8292918
- 负责人:
- 金额:$ 78.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAddressAerosolsAgeAlveolarAnabolismAnimalsAntitubercular AgentsAttenuatedAutopsyBacillus (bacterium)BeliefBiological AssayBody TemperatureC-reactive proteinCCL19 geneCCL2 geneCCL7 geneCD4 Positive T LymphocytesCatabolismCaviaCell WallCellsCessation of lifeCharacteristicsCholesterolChromosomesChronicClinicalCommunicable DiseasesConfocal MicroscopyDNA RepairDefectDevelopmentDiseaseDoseDrug resistanceEmergency SituationEnvironmentEnzyme-Linked Immunosorbent AssayExhibitsFailureFamilyFatty AcidsGenesGeneticGenomeGranulomaGranulomatousGrowthHealthHistopathologyHumanHypersensitivity skin testingHypoxiaImmune systemIn Situ HybridizationIndividualInfectionInflammatoryInterleukin-12IrrigationLesionLibrariesLiverLungLung Lavage FluidMacaca mulattaMammalian CellMeasurementMeasuresMetabolismMinorityModelingMonkeysMusMycobacterium tuberculosisNitrate ReductasesNutrientOperonOutputPathogenesisPathologyPathway interactionsPeptidoglycanPharmaceutical PreparationsPhasePhenotypePhosphotransferasesPhysiologicalPlayPrimatesProcessProductionPulmonary TuberculosisRegulonRelative (related person)ReportingResistanceRestReverse Transcriptase Polymerase Chain ReactionRoleSamplingSerumSimian Acquired Immunodeficiency SyndromeSouthern BlottingSpleenStagingSterolsStressSystemTestingTimeTuberculosisTuberculosis VaccinesVaccinesValidationVirulenceVirulence FactorsVirulentWeightarabanattenuationbasehygromycin Aimmune activationimmunopathologyin vivolipid transportlymph nodesmacrophagemalemembermortalitymouse modelmutantnitrate reductasenonhuman primateperipheral bloodresearch studyresponsesensortransposon site hybridizationtuberculosis drugsvector
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a global infectious disease emergency. Each year an estimated 8 million people develop, and about two million people die of TB. Synergy with AIDS, the emergence of drug-resistance and the lack of effective anti-TB drugs and vaccines has worsened this situation. New drugs and vaccines are urgently needed to effectively control TB. This requires a better understanding of how Mtb adapts to a wide-variety of environmental conditions, inevitably faced by it during the various stages of infection. Nonhuman Primates (NHPs), arguably, best model critical aspects of TB. Analysis of the mechanisms employed by Mtb to successfully infect and persist in NHP lungs would therefore be very useful. We studied genes essential for growth/survival of Mtb in the NHP lungs experimentally exposed to high doses of aerosols of an Mtb transposon mutant library. In this acute model of TB, 33.13% of all tested mutants were attenuated for in-vivo growth compared to the mouse model where only ~6% of all mutants are attenuated. The Mtb mutants attenuated for in-vivo survival in primates were involved in the transport of lipid virulence factors; biosynthesis of cell-wall arabinan and peptidoglycan, fatty-acids and polyketides; DNA repair; sterol metabolism and mammalian cell-entry (mce). Our study highlights the various virulence-mechanisms employed by Mtb for infection and to overcome the hostile environment encountered during infection of NHP lungs. We would like to leverage our ability to model the various clinical phases of human TB - acute, pulmonary TB, chronic-progressive TB and latent, asymptomatic TB in NHPs - to study the growth/survival phenotype profiles of Mtb mutants. Further, we would like to better understand the role of two Mtb pathways crucial for virulence and pathogenesis, using the NHP model. These include the mce1/mce4 operons, whose members were among mutants that were attenuated for growth in NHP lungs; and members of the dos regulon, which were surprisingly not attenuated in NHP lungs, in-spite of their well-defined roles in latency, persistence and defense against hypoxia.
PUBLIC HEALTH RELEVANCE: Tuberculosis (TB) is a global emergency, responsible for the death of an estimated 2 million people annually. Monkeys, due to their genetic and physiological similarities to humans, are a very good animal system to model TB. Out of the several hundreds of genes present in the chromosome of the tubercle bacillus, we have determined which ones are needed to establish a successful infection in the lungs of monkeys. These results will be compared to those obtained from animals with TB/AIDS co-infection. Genes from the mce (mammalian cell entry) family were among those which were attenuated in the NHP lungs. We will perform functional studies using Mycobacterium tuberculosis (Mtb) and defined mutants in mce genes, using our monkey model, to better understand their role in disease process.
描述(由申请人提供):结核病(TB)由结核分枝杆菌(Mtb)引起,是一种全球性传染病紧急情况。据估计,每年有 800 万人罹患结核病,约 200 万人死于结核病。与艾滋病的协同作用、耐药性的出现以及有效抗结核药物和疫苗的缺乏使这种情况更加恶化。迫切需要新药和疫苗来有效控制结核病。这需要更好地了解结核分枝杆菌如何适应各种环境条件,这是它在感染的各个阶段不可避免地要面对的。非人类灵长类动物 (NHP) 可以说是结核病关键方面的最佳模型。因此,分析 Mtb 成功感染 NHP 肺部并在其中持续存在的机制将非常有用。我们研究了 NHP 肺中 Mtb 生长/生存所必需的基因,该肺通过实验暴露于 Mtb 转座子突变体库的高剂量气溶胶。在这种结核病急性模型中,所有测试的突变体中有 33.13% 的体内生长被减毒,而小鼠模型中只有约 6% 的突变体被减毒。灵长类动物体内存活能力减弱的 Mtb 突变体参与脂质毒力因子的转运;细胞壁阿拉伯聚糖和肽聚糖、脂肪酸和聚酮化合物的生物合成; DNA修复;甾醇代谢和哺乳动物细胞进入(MCE)。我们的研究强调了 Mtb 用于感染和克服 NHP 肺部感染期间遇到的恶劣环境的各种毒力机制。我们希望利用我们对人类结核病各个临床阶段(急性、肺结核、慢性进行性结核病和 NHP 中潜伏、无症状结核病)进行建模的能力,来研究 Mtb 突变体的生长/生存表型概况。此外,我们希望使用 NHP 模型更好地了解对毒力和发病机制至关重要的两条 Mtb 途径的作用。其中包括 mce1/mce4 操纵子,其成员属于在 NHP 肺中生长减弱的突变体;令人惊讶的是,尽管它们在潜伏期、持久性和防御缺氧方面具有明确的作用,但它们在 NHP 肺部中却没有减弱。
公共卫生相关性:结核病 (TB) 是一种全球性紧急情况,每年造成约 200 万人死亡。由于猴子在遗传和生理上与人类相似,因此是模拟结核病的非常好的动物系统。在结核杆菌染色体中存在的数百个基因中,我们已经确定了在猴子肺部成功感染所需的哪些基因。这些结果将与从结核病/艾滋病合并感染的动物中获得的结果进行比较。来自 mce(哺乳动物细胞进入)家族的基因在 NHP 肺部中被减弱。我们将使用结核分枝杆菌 (Mtb) 和 mce 基因中定义的突变体,使用我们的猴子模型进行功能研究,以更好地了解它们在疾病过程中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deepak Kaushal其他文献
Deepak Kaushal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deepak Kaushal', 18)}}的其他基金
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
诱导支气管相关淋巴组织在潜伏性结核病中的作用
- 批准号:
10764569 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
Baboon model of long term effects of SARS-CoV-2 infection
SARS-CoV-2 感染长期影响的狒狒模型
- 批准号:
10413419 - 财政年份:2021
- 资助金额:
$ 78.3万 - 项目类别:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
结核病对 SIV 感染婴儿免疫系统发育和功能的影响
- 批准号:
10444441 - 财政年份:2021
- 资助金额:
$ 78.3万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10757101 - 财政年份:2020
- 资助金额:
$ 78.3万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10440359 - 财政年份:2020
- 资助金额:
$ 78.3万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10211126 - 财政年份:2020
- 资助金额:
$ 78.3万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10083390 - 财政年份:2020
- 资助金额:
$ 78.3万 - 项目类别:
相似国自然基金
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活性脂质Arlm-1介导的自噬流阻滞在儿童T细胞急性淋巴细胞白血病化疗耐药逆转中的作用机制研究
- 批准号:82300182
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
An mHealth implementation strategy to address the syndemic of mental illness, hypertension, and HIV in Uganda
解决乌干达精神疾病、高血压和艾滋病毒综合症的移动医疗实施战略
- 批准号:
10752992 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫中的 m6A mRNA 阅读器蛋白
- 批准号:
10615374 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
- 批准号:
10587658 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别: